ICON 9—an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

Osnat Elyashiv, Jonathan Ledermann, Gita Parmar, Laura Farrelly, Nicholas Counsell, Amanda Feeney, Fatima El-khouly, Ian Macdonald, Andreia Neto, Esther Arthur-darkwa, Eva Burnett, Gordon C Jayson, Linda Mileshkin, Charlie Gourley, Shibani Nicum

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)ijgc-2020-002073
JournalInternational Journal of Gynecological Cancer
DOIs
Publication statusPublished - 23 Oct 2020

Cite this